Novartis NVS
NYSE · Pharmaceutical Preparations$155.21−2.46%Nov 18 close · Databento
Data provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.
On the Wire
what NVS did at the next close after each storySep 17
Novartis and Ionis cholesterol trial falls short in late-stage setback
—Yahoo Finance · 11:21 AM ET
The Wire at 7 AM ET, free. Top stories with a bull and a bear case on each, every morning. No account needed.